WebJun 7, 2024 · C4T will host an investor event and webcast today, June 7, 2024, at 8 am E.T. to further discuss the pre-clinical data. Details of this event are included below. ... About C4 Therapeutics WebNov 1, 2024 · It's nice to see that C4 Therapeutics shareholders have gained 79% over the last year. We regret to report that the share price is down 0.8% over ninety days. Shorter term share price moves often ...
C4 Therapeutics Inc (CCCC) Stock: What Does the Chart Say …
WebApr 12, 2024 · Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions. ... C4 Therapeutics Inc (CCCC) stock has risen 0.31% while the S&P 500 is lower by -0.14% as of 11:06 AM on Wednesday, Apr 12. CCCC is higher by $0.01 from … WebAug 7, 2024 · Taking into account the latest results, the eleven analysts covering C4 Therapeutics provided consensus estimates of US$37.4m revenue in 2024, which would reflect a sizeable 25% decline on its ... caa mck review mr guns n gear
C4 Therapeutics Reports Second Quarter 2024 Financial Results …
WebDec 29, 2024 · C4 Therapeutics, Inc. (CCCC) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which ... WebMay 26, 2024 · C4 Therapeutics to Advance CFT8919, A Selective Degrader of EGFR L858R, Into IND-enabling Studies - read this article along with other careers information, tips and advice on BioSpace ... Details of this event are available on the Investors section of the C4T website, under Events & Presentations. June 1, 2024 – C4T will participate in a ... WebAug 10, 2024 · Investors have been pretty optimistic on C4 Therapeutics too, with the stock up 16% to US$11.70 over the past week. We'll be curious to see if these new estimates convince the market to lift the ... clover go offline mode